DrugInfoSys

Diltiazem (HCl)

Drug #245

Diltiazem is an anti-arrhythmic agent. Diltiazem (HCl) is a calcium channel blocking agent. It lowers the blood pressure by blocking calcium and relaxes the heart muscle and dilates the heart blood vessels. It has been known since the late 1800s that calcium influx was necessary for the contraction of muscle. The discovery of these channels also made possible the developemnet of clinically useful blocking drugs.

Primary Characteristics

It is of Synthetic origin and belongs to Benzothiazepin.

It belongs to Calcium L-channel antagonist pharmacological group on the basis of mechanism of action.

Molecular Weight: 451 · pKa: 7.7 · Solubility in Water: freely soluble · Solubility in Alcohol: 1 in 110 · Non-proprietary name: Diltiazem (HCl) · pH: 4.3.

Molecular structure of Diltiazem (HCl)

Pharmacokinetics

Absorption: Diltiazem (HCl) has an oral bioavailability is 90%, pre-systemic (first-pass) metabolism accounts for 50% (±5%).

Distribution: Diltiazem (HCl) has a volume of distribution is 5 l/kg. plasma protein binding is 80-90%.

Elimination: it is metabolised via extensive by liver, plasma half-life is avg 3-4.5 hr, renal excretion is major.

Advertisement

Indications

Contraindications

Diltiazem (HCl) is contraindicated in conditions like Bradycardia, Sick sinus syndrome, Av block of ii &iii degree.

Dosage

Diltiazem (HCl)'s dosage details are as follows:

DoseSingle DoseFrequencyRouteInstructions
Adult Dosage
60 – 540 mgEvery 8hFor Angina
90 mg90 mgTo maximum of 360mg of 540mg. for hypertension.
Paediatric Dosage (20kg)
No data.
Neonatal Dosage (3kg)
No data.

Drug Interactions

Unknown16 interactions
12 interactions
Major5 interactions
Moderate8 interactions

Always consult your physician for the change of dose regimen or an alternative drug of choice that may strictly be required.

Side Effects

Diltiazem (HCl) in overdosage may give rise to further complications which include Heart block , Hypoglycemia, GI hemorrhage.

Diltiazem (HCl) produces potentially life-threatening effects which include Paralytic ileus, Pedal edema, Sinus arrest, Atrioventricular conduction disturbances, Impaired left vntricular function , Facial flushing, Acute hepatic injury, Facial flushing. Careful monitoring is needed with proper medical management.

The signs and symptoms that are produced after acute overdosage of Diltiazem (HCl) are Hypotension, Junctional bradycardia, Low cardiac output.

Diltiazem (HCl) is known to cause more or less tolerable side effects which are usually transient. These include Asthenia , AV Block , Bradycardia , Constipation , Dizziness, Drowsiness, Fainting, Fever, Flushing, GI upset, Headache, Hypotension , Insomnia, Peripheral edema, Skin rashes, Sore throat, Swelling , Weight gain.

Warnings / Precautions

Diltiazem should be used with caution in patients with kidney or liver impairment, vetricular dysfunction, severe bradycardia, cardiogenic shock or congestive heart failure, sinoatrial nodal dysfunction. Consider decrease in dose of calcium channel blockers and monitor drug response in cirrhosis patients. Diltiazem should not be used in patient with acute myocardial infarction. It is classified as pregnancy category C and should be used during pregnancy with caution only when the benefit outweighs the risk to fetus.

Interference in Pathology

Diltiazem (HCl) may interfere in the diagnosis of Liver Function Test (LFT) .

Available Brands

Click on a strength to view available brands.

Storage Conditions

Diltiazem (HCl) should be stored Inj. Tab, Caps.

Drug Classification

  1. 1.12.3.2Calcium antagonists

Manufacturers